Last Updated : October 25, 2011
Details
FilesGeneric Name:
Silodosin
Project Status:
Complete
Therapeutic Area:
Benign prostatic hyperplasia
Manufacturer:
Watson Pharma Company
Call for patient/clinician input open:
Brand Name:
RAPAFLO
Project Line:
Reimbursement Review
Project Number:
SR0261-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Prostatic Hyperplasia, benign
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : October 25, 2011